Technical Analysis: If the support level will not be broken there might be an opportunity to go long.
Fundamental Analysis:
Gilead Was Approached by AstraZeneca About Potential Merger
Fundamental Analysis:
Gilead Was Approached by AstraZeneca About Potential Merger